Homologe Recombinatie Deficiency (HRD) als predictieve en prognostische genetische merker bij eierstokkanker - Van 'one-size-fits-all' naar een meer gepersonaliseerde behandelingsaanpak.
Does age matter? Examining career commitment as a moderator in the relationship between age-related HR/D practices and subjective career success for younger versus older academic staff
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial.
Crystal structure of the Bloom's syndrome helicase indicates a role for the HRDC domain in conformational changes
First trial of chemotherapy de-escalation in ovarian cancer (OC): A phase III randomized, open label study of niraparib maintenance after carboplatin and paclitaxel in patients with optimally debulked advanced (homologous recombination deficient) HRD high
CORDEX simulations (evaluation, historical, rcp85, rcp45 and rcp26) on a ca. 50 km grid over Europe based on ALARO-0 forced by CNRM-CM5
CORDEX simulations (evaluation, historical, rcp85, rcp45 and rcp26) on a ca. 12.5 km grid over Europe based on ALARO-0 forced by CNRM-CM5